Clinical Trials Browser

Active not recruiting × Has results × Kidney Neoplasms × Clear all

Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Site, Urologic Neoplasms

NCT03203473 2026-02-06

Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

Phase 2 Active not recruiting

85 enrolled 17 charts

Genitourinary

Kidney Neoplasms

NCT05696444 2025-11-25

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

Phase NA Active not recruiting

144 enrolled 22 charts

GenitourinaryGynecologic

Congenital Abnormalities, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Kidney Failure, Chronic, Kidney Neoplasms, Pelvic Neoplasms, Prostatic Neoplasms, Cystitis, Interstitial

NCT04195750 2025-04-29

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Phase 3 Active not recruiting

755 enrolled 28 charts 2 FDA

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04489771 2025-02-11

MK-6482-013

Phase 2 Active not recruiting

154 enrolled 19 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT03354390 2024-12-03

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Phase 1 Active not recruiting

17 enrolled 15 charts

Genitourinary

Kidney Neoplasms

Clinical Trials

Savolitinib vs. Sunitinib in MET-driven PRCC.

Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

MK-6482-013

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma